The Role of Poly Vinyl Pyrrolidone Iodine (PVP-I) in Preventing Cross-Infection during Dental Procedures: A Systematic Review in the COVID-19 Context
Vania Jovita Gunawan, Fitrina Rachmadanty Siregar, Agatha Ravi Vidiasratri, Dr Lisdrianto Hanindriyo
Journal of International Society of Preventive and Community Dentistry, doi:10.4103/jispcd.jispcd_78_24
Aim: As the dental community navigates the challenges posed by the coronavirus disease 2019 (COVID-19) pandemic, mitigating the risk of viral cross-transmission among dentists and dental clinic operators remains paramount. Polyvinyl pyrrolidone iodine (PVP-I) has emerged as a promising agent in reducing the chance of cross-transmission, primarily through its broad-spectrum antiseptic properties and ability to kill viruses rapidly. This study aimed to explore the role of PVP-I in preventing cross-infection of severe acute respiratory syndromecoronavirus 2 (SARS-CoV-2) and assess its effectiveness as a prophylaxis before dental treatment. Materials and Methods: A comprehensive search of multiple databases, including Science Direct, PubMed, Sage Journal, Cochrane, and Wiley Online Library, was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The study selection process utilized the Patient, Intervention, Comparison, Outcome, and Study Design framework (P: SARS-CoV-2 positive individuals, I: PVP-I mouthwash, C: various PVP-I concentrations, O: virucidal effect, S: randomized-controlled trials and clinical trials). Titles and abstracts were screened for relevance, and full-text articles were assessed for eligibility based on predefined inclusion and exclusion criteria. The risk of bias was assessed using the Cochrane Risk of Bias Tool version 2 for randomized controlled trials and Toxicological Data Reliability Assessment Tool for in vitro studies. A total of 11 articles (seven in vitro and four in vivo) were included in the systematic review. Results: Our findings suggest that PVP-I exhibits superior antiseptic properties compared to other agents, with gargling using PVP-I solutions of 0.2% and 0.5% demonstrating significant efficacy in reducing viral load in saliva. Notably, PVP-I showed rapid virucidal action, effectively reducing SARS-CoV-2 viral particles and potentially lowering the risk of cross-infection during dental procedures. However, despite these promising results in viral reduction, the evidence remains insufficient to definitively recommend PVP-I as a routine clinical prophylaxis for preventing cross-infection in dental care settings during the COVID-19 pandemic. Further large-scale clinical trials are necessary to establish its widespread use.
Conclusion: This systematic review highlights the potential of PVP-I as a critical antiseptic in dental settings to mitigate the risk of SARS-CoV-2 transmission. The rapid and significant reduction in viral load suggests that PVP-I could play a pivotal
financial support and sponsorship
Nil.
conflicts of interest There are no conflicts of interest.
References
Alsaleh, Alhussien, Alyamani, Alhussain, Alhijji et al., Efficacy of povidone-iodine nasal rinse and mouth wash in COVID-19 management: a prospective, randomized pilot clinical trial (povidone-iodine in COVID-19 management), BMC Infect Dis
Anderson, Sivalingam, Kang, Ananthanarayanan, Arumugam et al., Povidone-iodine demonstrates rapid in vitro virucidal activity against SARS-CoV-2, the virus causing COVID-19 disease, Infect Dis Ther
Arefin, Povidone iodine (PVP-I) oro-nasal spray: An effective shield for COVID-19 protection for health care worker (HCW), for all, Indian J Otolaryngol Head Neck Surg
Ather, Parolia, Ruparel, Efficacy of mouth rinses against SARS-CoV-2: A scoping review, Clin Infect Dis
Berkelman, Holland, Anderson, Increased bactericidal activity of dilute preparations of povidone-jodine solutions, J Clin Microbiol
Bidra, Pelletier, Westover, Frank, Brown et al., Comparison of in vitro inactivation of SARS CoV-2 with hydrogen peroxide and povidone-iodine oral antiseptic rinses, J Prosthod
Bidra, Pelletier, Westover, Frank, Brown et al., Comparison of in vitro inactivation of SARS CoV-2 with hydrogen peroxide and povidone-iodine oral antiseptic rinses, J Prosthodont
Bidra, Pelletier, Westover, Frank, Brown et al., Comparison of in vitro inactivation of SARS CoV-2 with hydrogen peroxide and povidone-iodine oral antiseptic rinses, J of Prosthod
Bidra, Pelletier, Westover, Frank, Brown et al., Rapid in-vitro inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using povidone-iodine oral antiseptic rinse, J Prosthod
Bidra, Pelletier, Westover, Frank, Brown et al., Rapid in-vitro inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using povidone-iodine oral antiseptic rinse, J Prosthodont
Bradley, Comparing in vitro and in vivo models as part of pre-clinical studies for COVID-19 medicines, Youth STEM Mat
Burton, Clarkson, Goulao, Glenny, Mcbain et al., Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them, Cochrane Data Syst Rev
Chaudhary, Melkonyan, Meethil, Saraswat, Hall et al., Estimating salivary carriage of severe acute respiratory syndrome coronavirus 2 in nonsymptomatic people and efficacy of mouthrinse in reducing viral load: A randomized controlled trial, J Am Dent Assoc
Davies, Buczkowski, Welch, Green, Mawer et al., Effective in vitro inactivation of SARS-CoV-2 by commercially available mouthwashes, J Gen Virol
Eggers, Koburger-Janssen, Eickmann, Zorn, In vitro bactericidal and virucidal efficacy of povidone-iodine gargle/ mouthwash against respiratory and oral tract pathogens, Infect Dis Ther
Elzein, Sater, Fakhreddine, Hanna, Feghali et al., In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial, J Evid Based Dent Pract
Farrell, Klatt-Cromwell, Schneider, Virology, epidemiology, pathogenesis, and control of covid-19, JAMA Otolaryngol Head Neck Surg
Frank, Brown, Capriotti, Westover, Pelletier et al., In vitro efficacy of a povidone-iodine nasal antiseptic for rapid inactivation of SARS-CoV-2, JAMA Otolaryngol Head Neck Surg
Frank, Capriotti, Brown, Tessema, Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era, Ear Nose Throat J
Garcia-Sanchez, Peña-Cardelles, Ordonez-Fernandez, Montero-Alonso, Kewalramani et al., Povidone-iodine as a pre-procedural mouthwash to reduce the salivary viral load of SARS-CoV-2: A systematic review of randomized controlled trials, Int J Environ Res Public Health
Gonçalves Brandão, Rocca, De Lima, Bocchi, A review of cost-effectiveness analysis: From theory to clinical practice, Medicine
Hassandarvish, Tiong, Mohamed, Arumugam, Ananthanarayanan et al., In vitro virucidal activity of povidone iodine gargle and mouthwash against SARS-CoV-2: implications for dental practice, Br Dent J
Henderson, Kimmelman, Fergusson, Grimshaw, Hackam, Threats to validity in the design and conduct of preclinical efficacy studies: A systematic review of guidelines for in vivo animal experiments, PLoS Med
Hoffmann, Kleine-Weber, Schroeder, Krüger, Herrler et al., SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell
Hu, Guo, Zhou, Shi, Characteristics of SARS-CoV-2 and COVID-19. Nature reviews microbiology, Nat Res
Idrees, Mcgowan, Fawzy, Abuderman, Balasubramaniam et al., Efficacy of mouth rinses and nasal spray in the inactivation of SARS-CoV-2: A systematic review and meta-analysis of in vitro and in vivo studies, Int J Environ Res Public Health
Ingre-Khans, Ågerstrand, Rudén, Beronius, Improving structure and transparency in reliability evaluations of data under REACH: suggestions for a systematic method, Hum Ecol Risk Assess
Jones, Biele, Mühlemann, Veith, Schneider et al., Estimating infectiousness throughout SARS-CoV-2 infection course, Science
Kramer, Eggers, Hübner, Walger, Steinmann et al., Virucidal gargling and virucidal nasal spray, GMS Hyg Infect Control
Kumar, Singh, Kaur, Pandey, Sharma et al., Wuhan to world: The COVID-19 pandemic. Frontiers in cellular and infection microbiology, Front Med SA
Köntös, Efficacy of "essential iodine drops" against severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), PLoS One
Lopez, Hutter, Pagin, Vélier, Véran et al., In vivo efficacy proof of concept of a largesize bioprinted dermo-epidermal substitute for permanent wound coverage, Front Bioeng Biotechnol
Lotfi, Hamblin, Rezaei, COVID-19: Transmission, prevention, and potential therapeutic opportunities, Clinica chimica acta. Elsevier B V
Maier, Bickerton, Britton, Methods and Protocols
Malik, Properties of Coronavirus and SARS-CoV-2, Malays J Pathol
Minozzi, Dwan, Borrelli, Filippini, Reliability of the revised Cochrane risk-of-bias tool for randomised trials (RoB2) improved with the use of implementation instruction, J Clin Epidemiol
Monstrey, Govaers, Lejuste, Lepelletier, De Oliveira, Evaluation of the role of povidone-iodine in the prevention of surgical site infections, Surg Open Sci
Mutluay, Egil, Effect of work environment and specialty degree of dentists on cross-infection control in COVID-19 pandemic, Braz J Infect Dis
Nair, Mrozikiewicz-Rakowska, Pinto, Physician, Stuermer et al., International Consensus Document: Use of wound antiseptics in practice
Page, Mckenzie, Bossuyt, Boutron, Hoffmann et al., The PRISMA 2020 statement: An updated guideline for reporting systematic reviews, BMJ
Pelletier, Tessema, Frank, Westover, Brown et al., Efficacy of povidone-iodine nasal and oral antiseptic preparations against severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), Ear Nose Throat J
Rackur, New aspects of mechanism of action of povidoneiodine, J Hosp Infect
Rosa, Dantas, Nascimento, Da Silva, De Oliveira et al., In vitro and in vivo models for studying sars-cov-2, the etiological agent responsible for covid-19 pandemic, Viruses
Ruppach, Log10 reduction factors in viral clearance studies, Bioprocess J
Schneider, Schwarz, Burkholder, Kopp-Schneider, Edler et al., ToxRTool," a new tool to assess the reliability of toxicological data, Toxicol Lett
Schreier, Erdos, Reimer, König, König et al., Molecular effects of povidone-iodine on relevant microorganisms: An electron-microscopic and biochemical study, Dermatology
Seneviratne, Balan, Ko, Udawatte, Lai et al., Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: Randomized control trial in Singapore, Infection
Shenoy, SARS-CoV-2 (COVID-19), viral load and clinical outcomes; lessons learned one year into the pandemic: A systematic review, World J Crit Care Med
Sirijatuphat, Leelarasamee, Puangpet, Thitithanyanont, A pilot study of 0.4% povidone-iodine nasal spray to eradicate SARS-CoV-2 in the Nasopharynx, Infect Drug Resist
Ting, Dahlkemper, Schwartz, Woodfork, Suzuki, Preprocedural viral load effects of oral antiseptics on SARS-CoV-2 in patients with COVID-19: A systematic review, Biomedicines
Torsten, Markus, Zorn, In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens, Infect Dis Ther
Van Doremalen, Bushmaker, Morris, Holbrook, Gamble et al., Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1, N Engl J Med
Wada, Nojima, Ogawa, Hayashi, Sugiyama et al., Relationship between virucidal efficacy and free iodine concentration of povidone-iodine in buffer solution, Biocontrol Sci
Wang, Hu, Xu, Hu, Wang, Complex in vitro model: A transformative model in drug development and precision medicine, Clin Trans Sci
Wang, Wu, Wang, Zhu, Shi et al., Virucidal effect of povidone-iodine against SARS-CoV-2 in vitro, J Int Med Res
Wiegand, Abel, Ruth, Elsner, Hipler, PH Influence on antibacterial efficacy of common antiseptic substances, Skin Pharmacol Physiol
Wood, Payne, The action of three antiseptics/disinfectants against enveloped and non-enveloped viruses, J Hosp Infect
Wood, Payne, The action of three antiseptics/disinfectants against enveloped and non-envelopedviruses, J Hosp Infect
Wu, Chen, Chan, The outbreak of COVID-19: An overview, J Chin Med Assoc
Wulandari, Bilimoria, Krasowska, Al-Bataineh, Beattie et al., Nanoscale iodophoric poly(vinyl amide) coatings for the complexation and release of iodine for antimicrobial surfaces, Appl Surf Sci
Xu, Guan, Investigating the complexation and release behaviors of iodine in poly(vinylpyrrolidone)-iodine systems through experimental and computational approaches, Ind Eng Chem Res
Zarabanda, Vukkadala, Phillips, Qian, Mfuh et al., The effect of povidone-iodine nasal spray on nasopharyngeal SARS-CoV-2 viral load: A randomized control trial, Laryngoscope
Zarabanda, Vukkadala, Phillips, Qian, Mfuh et al., The effect of povidone-iodine nasal spray on nasopharyngeal SARS-CoV-2 viral load: A randomized control trial, Laryngoscope
DOI record:
{
"DOI": "10.4103/jispcd.jispcd_78_24",
"ISSN": [
"2231-0762",
"2250-1002"
],
"URL": "http://dx.doi.org/10.4103/jispcd.jispcd_78_24",
"abstract": "<jats:title>A<jats:sc>bstract</jats:sc>\n </jats:title>\n <jats:sec>\n <jats:title>Aim:</jats:title>\n <jats:p>As the dental community navigates the challenges posed by the coronavirus disease 2019 (COVID-19) pandemic, mitigating the risk of viral cross-transmission among dentists and dental clinic operators remains paramount. Polyvinyl pyrrolidone iodine (PVP-I) has emerged as a promising agent in reducing the chance of cross-transmission, primarily through its broad-spectrum antiseptic properties and ability to kill viruses rapidly. This study aimed to explore the role of PVP-I in preventing cross-infection of severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) and assess its effectiveness as a prophylaxis before dental treatment.</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Materials and Methods:</jats:title>\n <jats:p>A comprehensive search of multiple databases, including Science Direct, PubMed, Sage Journal, Cochrane, and Wiley Online Library, was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The study selection process utilized the Patient, Intervention, Comparison, Outcome, and Study Design framework (P: SARS-CoV-2 positive individuals, I: PVP-I mouthwash, C: various PVP-I concentrations, O: virucidal effect, S: randomized-controlled trials and clinical trials). Titles and abstracts were screened for relevance, and full-text articles were assessed for eligibility based on predefined inclusion and exclusion criteria. The risk of bias was assessed using the Cochrane Risk of Bias Tool version 2 for randomized controlled trials and Toxicological Data Reliability Assessment Tool for <jats:italic toggle=\"yes\">in vitro</jats:italic> studies. A total of 11 articles (seven <jats:italic toggle=\"yes\">in vitro</jats:italic> and four <jats:italic toggle=\"yes\">in vivo</jats:italic>) were included in the systematic review.</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Results:</jats:title>\n <jats:p>Our findings suggest that PVP-I exhibits superior antiseptic properties compared to other agents, with gargling using PVP-I solutions of 0.2% and 0.5% demonstrating significant efficacy in reducing viral load in saliva. Notably, PVP-I showed rapid virucidal action, effectively reducing SARS-CoV-2 viral particles and potentially lowering the risk of cross-infection during dental procedures. However, despite these promising results in viral reduction, the evidence remains insufficient to definitively recommend PVP-I as a routine clinical prophylaxis for preventing cross-infection in dental care settings during the COVID-19 pandemic. Further large-scale clinical trials are necessary to establish its widespread use.</jats:p>\n </jats:sec>\n <jats:sec>\n <jats:title>Conclusion:</jats:title>\n <jats:p>This systematic review highlights the potential of PVP-I as a critical antiseptic in dental settings to mitigate the risk of SARS-CoV-2 transmission. The rapid and significant reduction in viral load suggests that PVP-I could play a pivotal role in infection control protocols. Nonetheless, further robust clinical trials are essential to confirm its efficacy and guide its adoption in routine dental care practices.</jats:p>\n </jats:sec>",
"assertion": [
{
"group": {
"label": "Publication History",
"name": "publication_history"
},
"label": "Received",
"name": "received",
"value": "2024-05-29"
},
{
"group": {
"label": "Publication History",
"name": "publication_history"
},
"label": "Accepted",
"name": "accepted",
"value": "2025-03-22"
}
],
"author": [
{
"affiliation": [
{
"name": "Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta, Indonesia"
}
],
"family": "Gunawan",
"given": "Vania Jovita",
"sequence": "first"
},
{
"affiliation": [
{
"name": "Department of Preventive and Community Dentistry, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta, Indonesia"
}
],
"family": "Siregar",
"given": "Fitrina Rachmadanty",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Preventive and Community Dentistry, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta, Indonesia"
}
],
"family": "Vidiasratri",
"given": "Agatha Ravi",
"sequence": "additional"
},
{
"affiliation": [
{
"name": "Department of Preventive and Community Dentistry, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta, Indonesia"
}
],
"family": "Hanindriyo",
"given": "Lisdrianto",
"sequence": "additional"
}
],
"container-title": "Journal of International Society of Preventive and Community Dentistry",
"container-title-short": "J Int Soc Prev Community Dent",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"lww.com",
"ovid.com"
]
},
"created": {
"date-parts": [
[
2025,
7,
2
]
],
"date-time": "2025-07-02T00:01:01Z",
"timestamp": 1751414461000
},
"deposited": {
"date-parts": [
[
2025,
7,
2
]
],
"date-time": "2025-07-02T00:01:14Z",
"timestamp": 1751414474000
},
"indexed": {
"date-parts": [
[
2025,
7,
2
]
],
"date-time": "2025-07-02T00:40:02Z",
"timestamp": 1751416802811,
"version": "3.41.0"
},
"is-referenced-by-count": 0,
"issue": "3",
"issued": {
"date-parts": [
[
2025,
5
]
]
},
"journal-issue": {
"issue": "3",
"published-print": {
"date-parts": [
[
2025
]
]
}
},
"language": "en",
"license": [
{
"URL": "http://creativecommons.org/licenses/by-nc-sa/4.0",
"content-version": "unspecified",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
5,
1
]
],
"date-time": "2025-05-01T00:00:00Z",
"timestamp": 1746057600000
}
}
],
"link": [
{
"URL": "https://journals.lww.com/10.4103/jispcd.jispcd_78_24",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "276",
"original-title": [],
"page": "197-210",
"prefix": "10.4103",
"published": {
"date-parts": [
[
2025,
5
]
]
},
"published-online": {
"date-parts": [
[
2025,
6,
30
]
]
},
"published-print": {
"date-parts": [
[
2025,
5
]
]
},
"publisher": "Ovid Technologies (Wolters Kluwer Health)",
"reference": [
{
"article-title": "Properties of Coronavirus and SARS-CoV-2",
"author": "Malik",
"first-page": "3",
"journal-title": "Malays J Pathol",
"key": "CIT0001-20250702",
"volume": "42",
"year": "2020"
},
{
"DOI": "10.1097/JCMA.0000000000000270",
"article-title": "The outbreak of COVID-19: An overview",
"author": "Wu",
"doi-asserted-by": "crossref",
"first-page": "217",
"journal-title": "J Chin Med Assoc",
"key": "CIT0002-20250702",
"volume": "83",
"year": "2020"
},
{
"article-title": "Methods and Protocols",
"author": "Maier",
"first-page": "1",
"journal-title": "Humana Press",
"key": "CIT0003-20250702",
"year": "2015"
},
{
"article-title": "Wuhan to world: The COVID-19 pandemic. Frontiers in cellular and infection microbiology",
"author": "Kumar",
"first-page": "1",
"journal-title": "Front Med SA",
"key": "CIT0004-20250702",
"volume": "11",
"year": "2021"
},
{
"article-title": "Characteristics of SARS-CoV-2 and COVID-19. Nature reviews microbiology",
"author": "Hu",
"first-page": "141",
"journal-title": "Nat Res",
"key": "CIT0005-20250702",
"volume": "19",
"year": "2021"
},
{
"DOI": "10.1016/j.cell.2020.02.052",
"article-title": "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor",
"author": "Hoffmann",
"doi-asserted-by": "crossref",
"first-page": "271",
"journal-title": "Cell",
"key": "CIT0007-20250702",
"volume": "181",
"year": "2020"
},
{
"article-title": "COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clinica chimica acta",
"author": "Lotfi",
"first-page": "254",
"journal-title": "Elsevier B V",
"key": "CIT0008-20250702",
"volume": "508",
"year": "2020"
},
{
"DOI": "10.1056/NEJMc2004973",
"article-title": "Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1",
"author": "van Doremalen",
"doi-asserted-by": "crossref",
"first-page": "1564",
"journal-title": "N Engl J Med",
"key": "CIT0009-20250702",
"volume": "382",
"year": "2020"
},
{
"DOI": "10.1016/j.bjid.2021.101592",
"article-title": "Effect of work environment and specialty degree of dentists on cross-infection control in COVID-19 pandemic",
"author": "Mutluay",
"doi-asserted-by": "crossref",
"first-page": "101592",
"journal-title": "Braz J Infect Dis",
"key": "CIT0010-20250702",
"volume": "25",
"year": "2021"
},
{
"key": "CIT0011-20250702",
"year": "2020"
},
{
"DOI": "10.1016/S0195-6701(98)90077-9",
"article-title": "The action of three antiseptics/disinfectants against enveloped and non-envelopedviruses",
"author": "Wood",
"doi-asserted-by": "crossref",
"first-page": "283",
"journal-title": "J Hosp Infect",
"key": "CIT0012-20250702",
"volume": "38",
"year": "1998"
},
{
"DOI": "10.1016/j.apsusc.2023.158422",
"article-title": "Nanoscale iodophoric poly(vinyl amide) coatings for the complexation and release of iodine for antimicrobial surfaces",
"author": "Wulandari",
"doi-asserted-by": "crossref",
"first-page": "1",
"journal-title": "Appl Surf Sci",
"key": "CIT0013-20250702",
"volume": "641",
"year": "2023"
},
{
"DOI": "10.1128/jcm.15.4.635-639.1982",
"article-title": "Increased bactericidal activity of dilute preparations of povidone-jodine solutions",
"author": "Berkelman",
"doi-asserted-by": "crossref",
"first-page": "635",
"journal-title": "J Clin Microbiol",
"key": "CIT0014-20250702",
"volume": "15",
"year": "1982"
},
{
"DOI": "10.1016/S0195-6701(85)80041-4",
"article-title": "New aspects of mechanism of action of povidone-iodine",
"author": "Rackur",
"doi-asserted-by": "crossref",
"first-page": "13",
"journal-title": "J Hosp Infect",
"key": "CIT0015-20250702",
"volume": "6",
"year": "1985"
},
{
"article-title": "The PRISMA 2020 statement: An updated guideline for reporting systematic reviews",
"author": "Page",
"first-page": "n71",
"journal-title": "BMJ. BMJ Publishing Group",
"key": "CIT0016-20250702",
"volume": "372",
"year": "2021"
},
{
"DOI": "10.1016/j.jclinepi.2021.09.021",
"article-title": "Reliability of the revised Cochrane risk-of-bias tool for randomised trials (RoB2) improved with the use of implementation instruction",
"author": "Minozzi",
"doi-asserted-by": "crossref",
"first-page": "99",
"journal-title": "J Clin Epidemiol",
"key": "CIT0017-20250702",
"volume": "141",
"year": "2022"
},
{
"DOI": "10.1016/j.toxlet.2009.05.013",
"article-title": "“ToxRTool,” a new tool to assess the reliability of toxicological data",
"author": "Schneider",
"doi-asserted-by": "crossref",
"first-page": "138",
"journal-title": "Toxicol Lett",
"key": "CIT0018-20250702",
"volume": "189",
"year": "2009"
},
{
"DOI": "10.1080/10807039.2018.1504275",
"article-title": "Improving structure and transparency in reliability evaluations of data under REACH: suggestions for a systematic method",
"author": "Ingre-Khans",
"doi-asserted-by": "crossref",
"first-page": "212",
"journal-title": "Hum Ecol Risk Assess",
"key": "CIT0019-20250702",
"volume": "26",
"year": "2020"
},
{
"DOI": "10.1111/jopr.13209",
"article-title": "Rapid in-vitro inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using povidone-iodine oral antiseptic rinse",
"author": "Bidra",
"doi-asserted-by": "crossref",
"first-page": "529",
"journal-title": "J Prosthod",
"key": "CIT0020-20250702",
"volume": "29",
"year": "2020"
},
{
"DOI": "10.1016/j.adaj.2021.05.021",
"article-title": "Estimating salivary carriage of severe acute respiratory syndrome coronavirus 2 in nonsymptomatic people and efficacy of mouthrinse in reducing viral load: A randomized controlled trial",
"author": "Chaudhary",
"doi-asserted-by": "crossref",
"first-page": "903",
"journal-title": "J Am Dent Assoc",
"key": "CIT0021-20250702",
"volume": "152",
"year": "2021"
},
{
"DOI": "10.1016/j.jebdp.2021.101584",
"article-title": "In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial",
"author": "Elzein",
"doi-asserted-by": "crossref",
"first-page": "101584",
"journal-title": "J Evid Based Dent Pract",
"key": "CIT0022-20250702",
"volume": "21",
"year": "2021"
},
{
"DOI": "10.1001/jamaoto.2020.3053",
"article-title": "In vitro efficacy of a povidone-iodine nasal antiseptic for rapid inactivation of SARS-CoV-2",
"author": "Frank",
"doi-asserted-by": "crossref",
"first-page": "1054",
"journal-title": "JAMA Otolaryngol Head Neck Surg",
"key": "CIT0023-20250702",
"volume": "146",
"year": "2020"
},
{
"DOI": "10.1177/0145561320957237",
"article-title": "Efficacy of povidone-iodine nasal and oral antiseptic preparations against severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2)",
"author": "Pelletier",
"doi-asserted-by": "crossref",
"first-page": "192S",
"journal-title": "Ear Nose Throat J",
"key": "CIT0024-20250702",
"volume": "100",
"year": "2021"
},
{
"DOI": "10.1007/s15010-020-01563-9",
"article-title": "Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: Randomized control trial in Singapore",
"author": "Seneviratne",
"doi-asserted-by": "crossref",
"first-page": "305",
"journal-title": "Infection",
"key": "CIT0025-20250702",
"volume": "49",
"year": "2021"
},
{
"DOI": "10.1002/lary.29935",
"article-title": "The effect of povidone-iodine nasal spray on nasopharyngeal SARS-CoV-2 viral load: A randomized control trial",
"author": "Zarabanda",
"doi-asserted-by": "crossref",
"first-page": "2089",
"journal-title": "Laryngoscope",
"key": "CIT0026-20250702",
"volume": "132",
"year": "2022"
},
{
"DOI": "10.1111/jopr.13220",
"article-title": "Comparison of in vitro inactivation of SARS CoV-2 with hydrogen peroxide and povidone-iodine oral antiseptic rinses",
"author": "Bidra",
"doi-asserted-by": "crossref",
"first-page": "599",
"journal-title": "J of Prosthod",
"key": "CIT0027-20250702",
"volume": "29",
"year": "2020"
},
{
"DOI": "10.1099/jgv.0.001578",
"article-title": "Effective in vitro inactivation of SARS-CoV- 2 by commercially available mouthwashes",
"author": "Davies",
"doi-asserted-by": "crossref",
"first-page": "001578",
"journal-title": "J Gen Virol",
"key": "CIT0028-20250702",
"volume": "102",
"year": "2021"
},
{
"DOI": "10.1007/s40121-018-0200-7",
"article-title": "In vitro bactericidal and virucidal efficacy of povidone-iodine gargle/mouthwash against respiratory and oral tract pathogens",
"author": "Eggers",
"doi-asserted-by": "crossref",
"first-page": "249",
"journal-title": "Infect Dis Ther",
"key": "CIT0029-20250702",
"volume": "7",
"year": "2018"
},
{
"DOI": "10.1177/03000605211063695",
"article-title": "Virucidal effect of povidone-iodine against SARS-CoV-2 in vitro",
"author": "Wang",
"doi-asserted-by": "crossref",
"first-page": "3000605211063695",
"journal-title": "J Int Med Res",
"key": "CIT0030-20250702",
"volume": "49",
"year": "2021"
},
{
"DOI": "10.1111/jopr.13220",
"article-title": "Comparison of in vitro inactivation of SARS CoV-2 with hydrogen peroxide and povidone-iodine oral antiseptic rinses",
"author": "Bidra",
"doi-asserted-by": "crossref",
"first-page": "599",
"journal-title": "J Prosthodont",
"key": "CIT0031-20250702",
"volume": "29",
"year": "2020"
},
{
"DOI": "10.1007/s40121-020-00316-3",
"article-title": "Povidone-iodine demonstrates rapid in vitro virucidal activity against SARS-CoV-2, the virus causing COVID-19 disease",
"author": "Anderson",
"doi-asserted-by": "crossref",
"first-page": "669",
"journal-title": "Infect Dis Ther",
"key": "CIT0032-20250702",
"volume": "9",
"year": "2020"
},
{
"article-title": "In vitro virucidal activity of povidone iodine gargle and mouthwash against SARS-CoV-2: implications for dental practice",
"author": "Hassandarvish",
"first-page": "1",
"journal-title": "Br Dent J",
"key": "CIT0033-20250702",
"volume": "10",
"year": "2020"
},
{
"DOI": "10.5492/wjccm.v10.i4.132",
"article-title": "SARS-CoV-2 (COVID-19), viral load and clinical outcomes; lessons learned one year into the pandemic: A systematic review",
"author": "Shenoy",
"doi-asserted-by": "crossref",
"first-page": "132",
"journal-title": "World J Crit Care Med",
"key": "CIT0034-20250702",
"volume": "10",
"year": "2021"
},
{
"DOI": "10.12665/J124.Ruppach",
"article-title": "Log10 reduction factors in viral clearance studies",
"author": "Ruppach",
"doi-asserted-by": "crossref",
"first-page": "24",
"journal-title": "Bioprocess J",
"key": "CIT0035-20250702",
"volume": "12",
"year": "2014"
},
{
"DOI": "10.1126/science.abi5273",
"article-title": "Estimating infectiousness throughout SARS-CoV-2 infection course",
"author": "Jones",
"doi-asserted-by": "crossref",
"first-page": "eabi5273",
"journal-title": "Science",
"key": "CIT0036-20250702",
"volume": "373",
"year": "2021"
},
{
"DOI": "10.1186/s12879-024-09137-y",
"article-title": "Efficacy of povidone-iodine nasal rinse and mouth wash in COVID-19 management: a prospective, randomized pilot clinical trial (povidone-iodine in COVID-19 management)",
"author": "Alsaleh",
"doi-asserted-by": "crossref",
"first-page": "271",
"journal-title": "BMC Infect Dis",
"key": "CIT0037-20250702",
"volume": "24",
"year": "2024"
},
{
"DOI": "10.2147/IDR.S391630",
"article-title": "A pilot study of 0.4% povidone-iodine nasal spray to eradicate SARS-CoV-2 in the Nasopharynx",
"author": "Sirijatuphat",
"doi-asserted-by": "crossref",
"first-page": "7529",
"journal-title": "Infect Drug Resist",
"key": "CIT0038-20250702",
"volume": "15",
"year": "2022"
},
{
"article-title": "Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them",
"author": "Burton",
"first-page": "CD013627",
"journal-title": "Cochrane Data Syst Rev",
"key": "CIT0039-20250702",
"volume": "9",
"year": "2020"
},
{
"DOI": "10.3390/ijerph191912148",
"article-title": "Efficacy of mouth rinses and nasal spray in the inactivation of SARS-CoV-2: A systematic review and meta-analysis of in vitro and in vivo studies",
"author": "Idrees",
"doi-asserted-by": "crossref",
"first-page": "12148",
"journal-title": "Int J Environ Res Public Health",
"key": "CIT0040-20250702",
"volume": "19",
"year": "2022"
},
{
"DOI": "10.4265/bio.21.21",
"article-title": "Relationship between virucidal efficacy and free iodine concentration of povidone-iodine in buffer solution",
"author": "Wada",
"doi-asserted-by": "crossref",
"first-page": "21",
"journal-title": "Biocontrol Sci",
"key": "CIT0041-20250702",
"volume": "21",
"year": "2016"
},
{
"DOI": "10.1111/jopr.13220",
"article-title": "Comparison of in vitro inactivation of SARS CoV-2 with hydrogen peroxide and povidone-iodine oral antiseptic rinses",
"author": "Bidra",
"doi-asserted-by": "crossref",
"first-page": "599",
"journal-title": "J Prosthod",
"key": "CIT0042-20250702",
"volume": "29",
"year": "2020"
},
{
"DOI": "10.1111/jopr.13209",
"article-title": "Rapid in-vitro inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using povidone-iodine oral antiseptic rinse",
"author": "Bidra",
"doi-asserted-by": "crossref",
"first-page": "529",
"journal-title": "J Prosthodont",
"key": "CIT0043-20250702",
"volume": "29",
"year": "2020"
},
{
"DOI": "10.1002/lary.29935",
"article-title": "The effect of povidone-iodine nasal spray on nasopharyngeal SARS-CoV-2 viral load: A randomized control trial",
"author": "Zarabanda",
"doi-asserted-by": "crossref",
"first-page": "2089",
"journal-title": "Laryngoscope",
"key": "CIT0044-20250702",
"volume": "132",
"year": "2021"
},
{
"DOI": "10.3390/ijerph19052877",
"article-title": "Povidone-iodine as a pre-procedural mouthwash to reduce the salivary viral load of SARS-CoV-2: A systematic review of randomized controlled trials",
"author": "Garcia-Sanchez",
"doi-asserted-by": "crossref",
"first-page": "2877",
"journal-title": "Int J Environ Res Public Health",
"key": "CIT0045-20250702",
"volume": "19",
"year": "2022"
},
{
"DOI": "10.1007/s40121-018-0200-7",
"article-title": "In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens",
"author": "Torsten",
"doi-asserted-by": "crossref",
"first-page": "249",
"journal-title": "Infect Dis Ther",
"key": "CIT0046-20250702",
"volume": "7",
"year": "2018"
},
{
"DOI": "10.1177/0145561320932318",
"article-title": "Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era",
"author": "Frank",
"doi-asserted-by": "crossref",
"first-page": "586",
"journal-title": "Ear Nose Throat J",
"key": "CIT0047-20250702",
"volume": "99",
"year": "2020"
},
{
"DOI": "10.1007/s12070-021-02525-9",
"article-title": "Povidone iodine (PVP-I) oro-nasal spray: An effective shield for COVID-19 protection for health care worker (HCW), for all",
"author": "Arefin",
"doi-asserted-by": "crossref",
"first-page": "2906",
"journal-title": "Indian J Otolaryngol Head Neck Surg",
"key": "CIT0048-20250702",
"volume": "74",
"year": "2022"
},
{
"DOI": "10.1016/j.sopen.2023.03.005",
"article-title": "Evaluation of the role of povidone-iodine in the prevention of surgical site infections",
"author": "Monstrey",
"doi-asserted-by": "crossref",
"first-page": "9",
"journal-title": "Surg Open Sci",
"key": "CIT0049-20250702",
"volume": "13",
"year": "2023"
},
{
"DOI": "10.1021/acs.iecr.0c04766",
"article-title": "Investigating the complexation and release behaviors of iodine in poly(vinylpyrrolidone)-iodine systems through experimental and computational approaches",
"author": "Xu",
"doi-asserted-by": "crossref",
"first-page": "22667",
"journal-title": "Ind Eng Chem Res",
"key": "CIT0050-20250702",
"volume": "59",
"year": "2020"
},
{
"article-title": "Efficacy of mouth rinses against SARS-CoV-2: A scoping review",
"author": "Ather",
"first-page": "3232",
"journal-title": "Clin Infect Dis",
"key": "CIT0051-20250702",
"volume": "71",
"year": "2020"
},
{
"DOI": "10.1001/jamaoto.2020.1622",
"article-title": "Virology, epidemiology, pathogenesis, and control of covid-19",
"author": "Farrell",
"doi-asserted-by": "crossref",
"first-page": "787",
"journal-title": "JAMA Otolaryngol Head Neck Surg",
"key": "CIT0052-20250702",
"volume": "146",
"year": "2020"
},
{
"article-title": "Virucidal gargling and virucidal nasal spray",
"author": "Kramer",
"first-page": "Doc02",
"journal-title": "GMS Hyg Infect Control",
"key": "CIT0053-20250702",
"volume": "16",
"year": "2021"
},
{
"DOI": "10.1159/000246043",
"article-title": "Molecular effects of povidone-iodine on relevant microorganisms: An electron-microscopic and biochemical study",
"author": "Schreier",
"doi-asserted-by": "crossref",
"first-page": "111",
"journal-title": "Dermatology",
"key": "CIT0054-20250702",
"volume": "195",
"year": "1997"
},
{
"DOI": "10.1016/S0195-6701(98)90077-9",
"article-title": "The action of three antiseptics/disinfectants against enveloped and non-enveloped viruses",
"author": "Wood",
"doi-asserted-by": "crossref",
"first-page": "283",
"journal-title": "J Hosp Infect",
"key": "CIT0055-20250702",
"volume": "38",
"year": "1997"
},
{
"DOI": "10.1371/journal.pone.0254341",
"article-title": "Efficacy of “essential iodine drops” against severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2)",
"author": "Köntös",
"doi-asserted-by": "crossref",
"first-page": "e0254341",
"journal-title": "PLoS One",
"key": "CIT0057-20250702",
"volume": "16",
"year": "2021"
},
{
"DOI": "10.51892/ysm.1.202103",
"article-title": "Comparing in vitro and in vivo models as part of pre-clinical studies for COVID-19 medicines",
"author": "Bradley",
"doi-asserted-by": "crossref",
"first-page": "27",
"journal-title": "Youth STEM Mat",
"key": "CIT0058-20250702",
"volume": "1",
"year": "2021"
},
{
"DOI": "10.3390/v13030379",
"article-title": "In vitro and in vivo models for studying sars-cov-2, the etiological agent responsible for covid-19 pandemic",
"author": "Rosa",
"doi-asserted-by": "crossref",
"first-page": "379",
"journal-title": "Viruses",
"key": "CIT0059-20250702",
"volume": "13",
"year": "2021"
},
{
"DOI": "10.1111/cts.13695",
"article-title": "Complex in vitro model: A transformative model in drug development and precision medicine",
"author": "Wang",
"doi-asserted-by": "crossref",
"first-page": "e13695",
"journal-title": "Clin Trans Sci",
"key": "CIT0060-20250702",
"volume": "17",
"year": "2024"
},
{
"DOI": "10.1159/000367632",
"article-title": "PH Influence on antibacterial efficacy of common antiseptic substances",
"author": "Wiegand",
"doi-asserted-by": "crossref",
"first-page": "147",
"journal-title": "Skin Pharmacol Physiol",
"key": "CIT0061-20250702",
"volume": "28",
"year": "2015"
},
{
"DOI": "10.3390/biomedicines11061694",
"article-title": "Preprocedural viral load effects of oral antiseptics on SARS-CoV-2 in patients with COVID-19: A systematic review",
"author": "Ting",
"doi-asserted-by": "crossref",
"first-page": "1694",
"journal-title": "Biomedicines",
"key": "CIT0062-20250702",
"volume": "11",
"year": "2023"
},
{
"DOI": "10.1371/journal.pmed.1001489",
"article-title": "Threats to validity in the design and conduct of preclinical efficacy studies: A systematic review of guidelines for in vivo animal experiments",
"author": "Henderson",
"doi-asserted-by": "crossref",
"first-page": "e1001489",
"journal-title": "PLoS Med",
"key": "CIT0063-20250702",
"volume": "10",
"year": "2013"
},
{
"DOI": "10.3389/fbioe.2023.1217655",
"article-title": "In vivo efficacy proof of concept of a large-size bioprinted dermo-epidermal substitute for permanent wound coverage",
"author": "Abellan Lopez",
"doi-asserted-by": "crossref",
"first-page": "1217655",
"journal-title": "Front Bioeng Biotechnol",
"key": "CIT0064-20250702",
"volume": "11",
"year": "2023"
},
{
"article-title": "A review of cost-effectiveness analysis: From theory to clinical practice",
"author": "Michelly Gonçalves Brandão",
"first-page": "e35614",
"journal-title": "Medicine (United States)",
"key": "CIT0065-20250702",
"volume": "102",
"year": "2023"
}
],
"reference-count": 63,
"references-count": 63,
"relation": {},
"resource": {
"primary": {
"URL": "https://journals.lww.com/10.4103/jispcd.jispcd_78_24"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "The Role of Poly Vinyl Pyrrolidone Iodine (PVP-I) in Preventing Cross-Infection during Dental Procedures: A Systematic Review in the COVID-19 Context",
"type": "journal-article",
"update-policy": "https://doi.org/10.1097/lww.0000000000001000",
"volume": "15"
}